Vivet presenting during Advanced Therapies 2020 in London
Vivet Therapeutics’ CEO, Jean-Philippe Combal
Vivet attending Jefferies 2019 London Healthcare Conference
Jean-Philippe Combal, Vivet Therapeutics’ CEO, and Thomas Daniel, BD Director, will be hosting 1×1 meetings during
Vivet Presenting at 2019 World Orphan Drug Congress Europe in Barcelona
Vivet Therapeutics CEO, Jean-Philippe Combal
VIVET THERAPEUTICS PRESENTING DURING AASLD – THE LIVER MEETING 2019 IN BOSTON
Dr. Gloria González-Aseguinolaza, Vivet Therapeutics CSO
Vivet Therapeutics Presenting New Results During 2019 ESGCT Annual Congress in Barcelona
Dr. Gloria González-Aseguinolaza, Vivet Therapeutics CSO & Head of the Gene Therapy
VIVET PRESENTING DURING 2019 GENE THERAPY FOR RARE DISORDERS EUROPE CONFERENCE IN LONDON
Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation (“Manufacturing of a New Gene Therapy Product: Long…
VIVET ATTENDING Chardan’s 3rd Annual Genetic Medicines Conference
Jean-Philippe Combal, Vivet Therapeutics’ CEO, will be hosting 1×1 meetings during Chardan ‘s 3rd Annual Genetic Medicines Conference, Oct 7-8,…
VIVET PRESENTING AT 2019 CELL & GENE MEETING ON THE MESA
Vivet Therapeutics CEO, Jean-Philippe Combal, will be giving a corporate presentation during 2019 Cell & Gene Meeting on the Mesa in Carlsbad on…
Vivet is attending the SSIEM 2019 Symposium in Rotterdam
Jean-Philippe Combal, Vivet Therapeutics’ CEO
VIVET ATTENDING BIO 2019 IN PHILADELPHIA ON JUNE 3-6
Vivet’s CEO, Jean-Philippe Combal and Thomas Daniel, BD Director, will be hosting 1×1 meetings during BIO 2019 in Philadelphia on June 3-6.
